Article Versions Notes

Bianco G, Gaibani P, Comini S, Boattini M, Banche G, Costa C, Cavallo R, Nordmann P. Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms. Antibiotics. 2022; 11(12):1681. https://doi.org/10.3390/antibiotics11121681

Bianco, Gabriele, Paolo Gaibani, Sara Comini, Matteo Boattini, Giuliana Banche, Cristina Costa, Rossana Cavallo, and Patrice Nordmann. 2022. "Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms" Antibiotics 11, no. 12: 1681. https://doi.org/10.3390/antibiotics11121681

Bianco, G., Gaibani, P., Comini, S., Boattini, M., Banche, G., Costa, C., Cavallo, R., & Nordmann, P. (2022). Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms. Antibiotics, 11(12), 1681. https://doi.org/10.3390/antibiotics11121681